ArticleFrontiers in endocrinology2021

Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma.

Deborah Cosentini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.